Literature DB >> 24754108

Drug treatments for Alzheimer's disease.

Graham A Jackson.   

Abstract

This article discusses the development and progress of treatment for Alzheimer's disease. Medical treatments have not changed since the late 1990s and have limited effects. They treat the symptoms patients experience but do not reverse the effects or repair neurological damage caused by Alzheimer's disease. Updated NICE guidance and likely future advances in treatment are also

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24754108

Source DB:  PubMed          Journal:  Nurs Times        ISSN： 0954-7762


  3 in total

1.  CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study.

Authors:  Adrià Dangla-Valls; José Luis Molinuevo; Jordi Altirriba; Raquel Sánchez-Valle; Daniel Alcolea; Juan Fortea; Lorena Rami; Mircea Balasa; Cristina Muñoz-García; Mario Ezquerra; Rubén Fernández-Santiago; Alberto Lleó; Albert Lladó; Anna Antonell
Journal:  Mol Neurobiol       Date:  2016-10-13       Impact factor: 5.590

2.  A novel acetylcholinesterase inhibitor and calcium channel blocker SCR-1693 improves Aβ25-35-impaired mouse cognitive function.

Authors:  Zhengping Zhang; Rong Chen; Wenji An; Chunmei Wang; Gaoyong Liao; Xiaoliang Dong; Aijing Bi; Zhimin Yin; Lan Luo
Journal:  Psychopharmacology (Berl)       Date:  2015-11-11       Impact factor: 4.530

3.  Designer Self-Assemble Peptides Maximize the Therapeutic Benefits of Neural Stem Cell Transplantation for Alzheimer's Disease via Enhancing Neuron Differentiation and Paracrine Action.

Authors:  Guo-Hong Cui; Shui-Jin Shao; Jia-Jun Yang; Jian-Ren Liu; Hai-Dong Guo
Journal:  Mol Neurobiol       Date:  2015-01-14       Impact factor: 5.590
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.